CYNATA THERAPEUTICS LIMITED - Announcements

8.82%

18.5¢

Market Cap $41.80M

Healthcare Biotechnology

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Announcements

Filter Results

All Price Sensitive Only

CYP	CYP Enters Letter of Intent for Strategic Alliance in Japan	PRICE SENSITIVE	03/12/15	164.73KB	Share
CYP	Expiry of Unlisted Options		01/12/15	148.5KB	Share
CYP	Results of Annual General Meeting		11/11/15	107.02KB	Share
CYP	MD's AGM Presentation		11/11/15	1.01MB	Share
CYP	Restricted Securities to be Release from Escrow		06/11/15	148.07KB	Share
CYP	Cynata Engages CRO to Conduct GvHD Clinical Trial	PRICE SENSITIVE	05/11/15	179.43KB	Share
CYP	Activities Report & Appendix 4C		29/10/15	267.41KB	Share
CYP	CYP in Major New Collaboration for Cell Therapy for Cancer	PRICE SENSITIVE	14/10/15	162.66KB	Share
CYP	Annual Report to Shareholders		06/10/15	884.12KB	Share
CYP	Notice of Annual General Meeting/Proxy Form		06/10/15	603.66KB	Share
CYP	Cynata to Present at Rodman & Renshaw Investment Conference		07/09/15	152.02KB	Share
CYP	SeeThruEquity Initiates Cynata Reasearch Coverage		03/09/15	148.16KB	Share
CYP	Appendix 4G		21/08/15	96.94KB	Share
CYP	Appendix 4E & FInancial Statements	PRICE SENSITIVE	21/08/15	851.5KB	Share
CYP	Activities Report & Appendix 4C	PRICE SENSITIVE	30/07/15	188.83KB	Share
CYP	Cynata in Heart Disease Collaboration with Uni of Sydney	PRICE SENSITIVE	30/07/15	177.46KB	Share
CYP	Information Required Under Listing Rule 3.10.5A		17/07/15	103.2KB	Share
CYP	Section 708A Notice		17/07/15	103.13KB	Share
CYP	Appendix 3B		17/07/15	182.44KB	Share
CYP	Section 708A Notice		15/07/15	105.02KB	Share
CYP	Private Placement to US Institutional Investors Completed	PRICE SENSITIVE	15/07/15	159.94KB	Share
CYP	R&D Tax Incentive	PRICE SENSITIVE	25/05/15	142.27KB	Share
CYP	Cynata - Cymerus Progress Report	PRICE SENSITIVE	21/05/15	175.77KB	Share
CYP	Response to ASX Query	PRICE SENSITIVE	08/05/15	101.59KB	Share
CYP	Activity Report & Appendix 4C	PRICE SENSITIVE	30/04/15	211.86KB	Share
CYP	Appendix 3Y-John Chiplin		30/03/15	23.14KB	Share
CYP	Cynata CEO to Chair World Congress Session on Stem Cells		18/03/15	150.75KB	Share
CYP	Appendix 3Y-Stewart Washer		16/03/15	25.2KB	Share
CYP	Executive Services Contracts Renewed/Vesting Conditions Met		16/03/15	169.25KB	Share
CYP	Commences Further Stage of Stem Cell Manufacturing Program	PRICE SENSITIVE	12/03/15	147.39KB	Share
CYP	Director Options Vesting Condition Met		06/03/15	145.5KB	Share
CYP	Cynata Presenting at 8th Annual ASX Spotlight New York 2015		05/03/15	148.89KB	Share
CYP	Appendix 4D & Half-Year Financial Statements	PRICE SENSITIVE	26/02/15	1.9MB	Share
CYP	CYP Investor Presentation-February 2015		23/02/15	1.07MB	Share
CYP	BBY Updates Cynata Research Coverage		20/02/15	143.82KB	Share
CYP	Cynata Achieves Major Stem Cell Manufacturing Milestone	PRICE SENSITIVE	19/02/15	166.91KB	Share
CYP	Trading Halt	PRICE SENSITIVE	17/02/15	191.79KB	Share
CYP	Cynata Engages CRO to Plan Clinical Trial		16/02/15	155.04KB	Share
CYP	Change of Share Registry		13/02/15	142.99KB	Share
CYP	Cynata Engages Leading US Investor Relations Firm	PRICE SENSITIVE	12/02/15	160.97KB	Share
CYP	Cynata Partners with Univeristy of Western Australia	PRICE SENSITIVE	03/02/15	191.19KB	Share
CYP	Activity Report & Appendix 4C	PRICE SENSITIVE	30/01/15	211.43KB	Share
CYP	Top 20 Shareholders		15/01/15	146.67KB	Share
CYP	Section 708A Notice		14/01/15	98.66KB	Share
CYP	Appendix 3B		14/01/15	176.18KB	Share
CYP	Section 708A Notice		06/01/15	99.05KB	Share
CYP	Completion of Exercise of Underwritten Listed Options		06/01/15	435.31KB	Share
CYP	Section 708A Notice		31/12/14	98.87KB	Share
CYP	Appendix 3B-Exercise of Listed Options		31/12/14	174.08KB	Share
CYP	Section 708A Notice		24/12/14	98.81KB	Share
CYP	Appendix 3B-Exercise of Listed Options		24/12/14	174.06KB	Share
CYP	Appendix 3Y-Peter Webse		18/12/14	24.38KB	Share
CYP	Section 708A Notice		18/12/14	99.19KB	Share
CYP	Appendix 3B-Exercise of Listed Options		18/12/14	176.6KB	Share
CYP	Section 708A Notice		11/12/14	99.31KB	Share
CYP	Appendix 3B-Exercise of Listed Options		11/12/14	176.68KB	Share
CYP	Section 708A Notice		05/12/14	98.72KB	Share
CYP	Appendix 3B - Exercise of Listed Options		05/12/14	176.35KB	Share
CYP	CYP to Present at Major International Stem Cell Conference		04/12/14	142.04KB	Share
CYP	Notification of Expiry of Listed Options		01/12/14	193.04KB	Share
CYP	Cynata Listed Options Fully Underwritten	PRICE SENSITIVE	25/11/14	145.09KB	Share
CYP	Appendix 3B-Release of Shares from Escrow		24/11/14	176.73KB	Share
CYP	Appendix 3X-Dr John Chiplin		18/11/14	63.25KB	Share
CYP	Appendix 3Z-Howard Digby		18/11/14	18.98KB	Share
CYP	Cynata Board Changes Implemented		18/11/14	141.09KB	Share
CYP	Results of Annual General Meeting		18/11/14	110.7KB	Share
CYP	CEO Presentation to AGM		18/11/14	983.4KB	Share
CYP	Section 708A Notice		14/11/14	99.28KB	Share
CYP	Appendix 3B-Exercise of Listed Options		14/11/14	176.14KB	Share
CYP	Section 708A Notice		12/11/14	97.92KB	Share
CYP	Appendix 3B - Exercise of Listed Options		12/11/14	175.99KB	Share
CYP	Restricted Securities to be Released from ASX Escrow		07/11/14	141.54KB	Share
CYP	Australian Patent for Core Cynata Technology	PRICE SENSITIVE	06/11/14	145.48KB	Share
CYP	Activity Report & Appendix 4C	PRICE SENSITIVE	31/10/14	210.45KB	Share
CYP	BBY Initiates Cynata Research Coverage		27/10/14	140.62KB	Share
CYP	Cynata to Appoint Dr John Chiplin to Board of Directors		23/10/14	148.75KB	Share
CYP	Section 708A Notice		22/10/14	97.72KB	Share
CYP	Appendix 3B-Exercise of Listed Options		22/10/14	175.93KB	Share
CYP	Annual Report to shareholders		16/10/14	4.38MB	Share
CYP	Notice of Annual General Meeting/Proxy Form		16/10/14	226.7KB	Share
CYP	Appendix 3B - Exercise of Listed Options		26/09/14	176.22KB	Share
CYP	Section 708A Notice		26/09/14	98.05KB	Share
CYP	Cynata Announces Landmark Licensing Deal	PRICE SENSITIVE	18/09/14	149.65KB	Share
CYP	Appendix 3B - Issue of Unlisted Options		11/09/14	177KB	Share
CYP	Section 708A Notice		09/09/14	98.04KB	Share
CYP	Appendix 3B - Exercise of Listed Options		09/09/14	176.13KB	Share
CYP	Cynata Initiates European Regulatory Process	PRICE SENSITIVE	03/09/14	142.85KB	Share
CYP	Cynata Responds to Option Transaction Queries		03/09/14	140.5KB	Share
CYP	Appendix 4E & Financial Statements	PRICE SENSITIVE	26/08/14	4.32MB	Share
CYP	Activity Report & Appendix 4C	PRICE SENSITIVE	31/07/14	273.48KB	Share
CYP	CYP Contracts UW to Advance Cymerus Product Development	PRICE SENSITIVE	28/07/14	146.97KB	Share
CYP	Contracts Leading CRO to Conduct Cymerus Preclinical Studies	PRICE SENSITIVE	14/07/14	69.69KB	Share
CYP	Cynata Announces Partnership Agreement		11/06/14	465.74KB	Share
CYP	Leading Brokerage Initiates Cynata Resarch Coverage		02/06/14	139.23KB	Share
CYP	Appendix 3B - Issue of Unlisted Options		29/05/14	176.41KB	Share
CYP	Appendix 3Y - Stewart Washer		22/05/14	24.67KB	Share
CYP	Appendix 3Y - Ross Macdonald		22/05/14	23.7KB	Share
CYP	Vesting of Unlisted Options		19/05/14	139.97KB	Share
CYP	CYP to Participate in Major International Stem Cell Conf		13/05/14	141.38KB	Share
CYP	Activity Report & Appendix 4C	PRICE SENSITIVE	29/04/14	275.1KB	Share

CYP CYP Enters Letter of Intent for Strategic Alliance in Japan
03/12/15	PRICE SENSITIVE	164.73KB	Share
CYP Expiry of Unlisted Options
01/12/15		148.5KB	Share
CYP Results of Annual General Meeting
11/11/15		107.02KB	Share
CYP MD's AGM Presentation
11/11/15		1.01MB	Share
CYP Restricted Securities to be Release from Escrow
06/11/15		148.07KB	Share
CYP Cynata Engages CRO to Conduct GvHD Clinical Trial
05/11/15	PRICE SENSITIVE	179.43KB	Share
CYP Activities Report & Appendix 4C
29/10/15		267.41KB	Share
CYP CYP in Major New Collaboration for Cell Therapy for Cancer
14/10/15	PRICE SENSITIVE	162.66KB	Share
CYP Annual Report to Shareholders
06/10/15		884.12KB	Share
CYP Notice of Annual General Meeting/Proxy Form
06/10/15		603.66KB	Share
CYP Cynata to Present at Rodman & Renshaw Investment Conference
07/09/15		152.02KB	Share
CYP SeeThruEquity Initiates Cynata Reasearch Coverage
03/09/15		148.16KB	Share
CYP Appendix 4G
21/08/15		96.94KB	Share
CYP Appendix 4E & FInancial Statements
21/08/15	PRICE SENSITIVE	851.5KB	Share
CYP Activities Report & Appendix 4C
30/07/15	PRICE SENSITIVE	188.83KB	Share
CYP Cynata in Heart Disease Collaboration with Uni of Sydney
30/07/15	PRICE SENSITIVE	177.46KB	Share
CYP Information Required Under Listing Rule 3.10.5A
17/07/15		103.2KB	Share
CYP Section 708A Notice
17/07/15		103.13KB	Share
CYP Appendix 3B
17/07/15		182.44KB	Share
CYP Section 708A Notice
15/07/15		105.02KB	Share
CYP Private Placement to US Institutional Investors Completed
15/07/15	PRICE SENSITIVE	159.94KB	Share
CYP R&D Tax Incentive
25/05/15	PRICE SENSITIVE	142.27KB	Share
CYP Cynata - Cymerus Progress Report
21/05/15	PRICE SENSITIVE	175.77KB	Share
CYP Response to ASX Query
08/05/15	PRICE SENSITIVE	101.59KB	Share
CYP Activity Report & Appendix 4C
30/04/15	PRICE SENSITIVE	211.86KB	Share
CYP Appendix 3Y-John Chiplin
30/03/15		23.14KB	Share
CYP Cynata CEO to Chair World Congress Session on Stem Cells
18/03/15		150.75KB	Share
CYP Appendix 3Y-Stewart Washer
16/03/15		25.2KB	Share
CYP Executive Services Contracts Renewed/Vesting Conditions Met
16/03/15		169.25KB	Share
CYP Commences Further Stage of Stem Cell Manufacturing Program
12/03/15	PRICE SENSITIVE	147.39KB	Share
CYP Director Options Vesting Condition Met
06/03/15		145.5KB	Share
CYP Cynata Presenting at 8th Annual ASX Spotlight New York 2015
05/03/15		148.89KB	Share
CYP Appendix 4D & Half-Year Financial Statements
26/02/15	PRICE SENSITIVE	1.9MB	Share
CYP CYP Investor Presentation-February 2015
23/02/15		1.07MB	Share
CYP BBY Updates Cynata Research Coverage
20/02/15		143.82KB	Share
CYP Cynata Achieves Major Stem Cell Manufacturing Milestone
19/02/15	PRICE SENSITIVE	166.91KB	Share
CYP Trading Halt
17/02/15	PRICE SENSITIVE	191.79KB	Share
CYP Cynata Engages CRO to Plan Clinical Trial
16/02/15		155.04KB	Share
CYP Change of Share Registry
13/02/15		142.99KB	Share
CYP Cynata Engages Leading US Investor Relations Firm
12/02/15	PRICE SENSITIVE	160.97KB	Share
CYP Cynata Partners with Univeristy of Western Australia
03/02/15	PRICE SENSITIVE	191.19KB	Share
CYP Activity Report & Appendix 4C
30/01/15	PRICE SENSITIVE	211.43KB	Share
CYP Top 20 Shareholders
15/01/15		146.67KB	Share
CYP Section 708A Notice
14/01/15		98.66KB	Share
CYP Appendix 3B
14/01/15		176.18KB	Share
CYP Section 708A Notice
06/01/15		99.05KB	Share
CYP Completion of Exercise of Underwritten Listed Options
06/01/15		435.31KB	Share
CYP Section 708A Notice
31/12/14		98.87KB	Share
CYP Appendix 3B-Exercise of Listed Options
31/12/14		174.08KB	Share
CYP Section 708A Notice
24/12/14		98.81KB	Share
CYP Appendix 3B-Exercise of Listed Options
24/12/14		174.06KB	Share
CYP Appendix 3Y-Peter Webse
18/12/14		24.38KB	Share
CYP Section 708A Notice
18/12/14		99.19KB	Share
CYP Appendix 3B-Exercise of Listed Options
18/12/14		176.6KB	Share
CYP Section 708A Notice
11/12/14		99.31KB	Share
CYP Appendix 3B-Exercise of Listed Options
11/12/14		176.68KB	Share
CYP Section 708A Notice
05/12/14		98.72KB	Share
CYP Appendix 3B - Exercise of Listed Options
05/12/14		176.35KB	Share
CYP CYP to Present at Major International Stem Cell Conference
04/12/14		142.04KB	Share
CYP Notification of Expiry of Listed Options
01/12/14		193.04KB	Share
CYP Cynata Listed Options Fully Underwritten
25/11/14	PRICE SENSITIVE	145.09KB	Share
CYP Appendix 3B-Release of Shares from Escrow
24/11/14		176.73KB	Share
CYP Appendix 3X-Dr John Chiplin
18/11/14		63.25KB	Share
CYP Appendix 3Z-Howard Digby
18/11/14		18.98KB	Share
CYP Cynata Board Changes Implemented
18/11/14		141.09KB	Share
CYP Results of Annual General Meeting
18/11/14		110.7KB	Share
CYP CEO Presentation to AGM
18/11/14		983.4KB	Share
CYP Section 708A Notice
14/11/14		99.28KB	Share
CYP Appendix 3B-Exercise of Listed Options
14/11/14		176.14KB	Share
CYP Section 708A Notice
12/11/14		97.92KB	Share
CYP Appendix 3B - Exercise of Listed Options
12/11/14		175.99KB	Share
CYP Restricted Securities to be Released from ASX Escrow
07/11/14		141.54KB	Share
CYP Australian Patent for Core Cynata Technology
06/11/14	PRICE SENSITIVE	145.48KB	Share
CYP Activity Report & Appendix 4C
31/10/14	PRICE SENSITIVE	210.45KB	Share
CYP BBY Initiates Cynata Research Coverage
27/10/14		140.62KB	Share
CYP Cynata to Appoint Dr John Chiplin to Board of Directors
23/10/14		148.75KB	Share
CYP Section 708A Notice
22/10/14		97.72KB	Share
CYP Appendix 3B-Exercise of Listed Options
22/10/14		175.93KB	Share
CYP Annual Report to shareholders
16/10/14		4.38MB	Share
CYP Notice of Annual General Meeting/Proxy Form
16/10/14		226.7KB	Share
CYP Appendix 3B - Exercise of Listed Options
26/09/14		176.22KB	Share
CYP Section 708A Notice
26/09/14		98.05KB	Share
CYP Cynata Announces Landmark Licensing Deal
18/09/14	PRICE SENSITIVE	149.65KB	Share
CYP Appendix 3B - Issue of Unlisted Options
11/09/14		177KB	Share
CYP Section 708A Notice
09/09/14		98.04KB	Share
CYP Appendix 3B - Exercise of Listed Options
09/09/14		176.13KB	Share
CYP Cynata Initiates European Regulatory Process
03/09/14	PRICE SENSITIVE	142.85KB	Share
CYP Cynata Responds to Option Transaction Queries
03/09/14		140.5KB	Share
CYP Appendix 4E & Financial Statements
26/08/14	PRICE SENSITIVE	4.32MB	Share
CYP Activity Report & Appendix 4C
31/07/14	PRICE SENSITIVE	273.48KB	Share
CYP CYP Contracts UW to Advance Cymerus Product Development
28/07/14	PRICE SENSITIVE	146.97KB	Share
CYP Contracts Leading CRO to Conduct Cymerus Preclinical Studies
14/07/14	PRICE SENSITIVE	69.69KB	Share
CYP Cynata Announces Partnership Agreement
11/06/14		465.74KB	Share
CYPLeading Brokerage Initiates Cynata Resarch Coverage
02/06/14		139.23KB	Share
CYPAppendix 3B - Issue of Unlisted Options
29/05/14		176.41KB	Share
CYPAppendix 3Y - Stewart Washer
22/05/14		24.67KB	Share
CYPAppendix 3Y - Ross Macdonald
22/05/14		23.7KB	Share
CYPVesting of Unlisted Options
19/05/14		139.97KB	Share
CYPCYP to Participate in Major International Stem Cell Conf
13/05/14		141.38KB	Share
CYPActivity Report & Appendix 4C
29/04/14	PRICE SENSITIVE	275.1KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 18.5¢		Change 0.015(8.82%)		Mkt cap ! $41.80M

Open	High	Low	Value	Volume
17.5¢	18.5¢	17.0¢	$21.36K	121.2K

Buyers (Bids)

No.	Vol.	Price($)
1	15599	18.0¢

Sellers (Offers)

Price($)	Vol.	No.
18.5¢	27303	2

View Market Depth

No.	Vol.	Price($)
3	50585	0.170
4	141820	0.165
7	235931	0.160
7	385725	0.155
5	136379	0.150

Price($)	Vol.	No.
0.185	27303	2
0.190	75000	1
0.195	6764	2
0.200	55400	2
0.205	6245	1

Last trade - 16.10pm 08/08/2025 (20 minute delay)

CYP (ASX) Chart

CYNATA THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories